Character Biosciences Expands Leadership Team with Key Appointments and Announces Series B Extension

JERSEY CITY, N.J.--(BUSINESS WIRE)--Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, today announced the expansion of its leadership team with four senior appointments, including Robert Kim, M.D., MBA as Chief Medical Officer, Daniel Elgort, Ph.D. as Chief Data & Analytics Officer, Josh Buddle as Head of Clinical Network and Longitudinal Research, and Jessamyn Wead as Head of People. The company also announced an expansion of its Seri